Literature DB >> 61635

Immunological enhancement of rat renal allografts using rabbit antisera with specificity for rat transplantation antigens.

I V Hutchinson, H Zola, J R Batchelor.   

Abstract

Rabbits immunized with particulate and soluble preparations of rat lymphoid tissue of the HO strain produced antisera which reacted without strain specificity on rat lymphocytes. Absorption of the sera with tissue from the AS strain of rat removed the antibodies reacting with AS tissue leaving activity against HO cells only. Studies with backcross rats showed that the antigens detected by these sera were products of the AgB genes or genes segragating with them. The immunosuppressive activity of rabbit antisera specific for Ag-B5 rat transplantation antigens was tested in a rat renal allograft assay. Some of the antisera markedly prolonged the survival of (AS X HO)F1 kidneys transplanted to AS rats. The prolongation of graft survival was not due to ALS activity since the sera were active in the absence of antibody directed against recipient antigens. There was no correlation between in vivo enhancement and anti-donor lymphocytotoxic titres of the xenoantisera.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61635     DOI: 10.1097/00007890-197609000-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  The major histocompatibility complex--comparison in the mouse, man, and the rat. A review.

Authors:  T J Gill; D V Cramer; H W Kunz
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

2.  Acute antibody-mediated rejection of skin grafts without involvement of granulocytes or complement.

Authors:  M J Bogman; I M Cornelissen; R A Koene
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

3.  Opsonization of tumor-reactive T cells in SJL/J mice bearing syngeneic tumors.

Authors:  I V Hutchinson; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.